These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6455224)

  • 21. Regulation of in vitro cytotoxic T lymphocyte generation. III. Interactions or regulatory T cell subsets in suppressor and target populations.
    Schwartz A; Gershon RK
    J Mol Cell Immunol; 1984; 1(4):237-52. PubMed ID: 6152894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular interactions in the human T-T autologous mixed lymphocyte reaction.
    Gupta S
    Behring Inst Mitt; 1983 May; (72):101-6. PubMed ID: 6242329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limiting dilution analysis of alloantigen-reactive T lymphocytes. IV. High frequency of cytolytic T lymphocyte precursor cells in MLC blasts separated by velocity sedimentation.
    Maryanski JL; MacDonald HR; Cerottini JC
    J Immunol; 1980 Jan; 124(1):42-7. PubMed ID: 6444230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses.
    Ryser JE; MacDonald HR
    J Immunol; 1979 May; 122(5):1691-6. PubMed ID: 156218
    [No Abstract]   [Full Text] [Related]  

  • 25. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
    Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
    J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of suppressor cells in the autologous mixed lymphocyte reaction.
    Fitzharris P; Knight RA
    Clin Exp Immunol; 1981 Oct; 46(1):185-95. PubMed ID: 6461452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ia antigen on peripheral blood mononuclear leukocytes in man. II. Functional studies of HLA-DR-positive T cells activated in mixed lymphocyte reactions.
    Engleman EG; Benike CJ; Charron DJ
    J Exp Med; 1980 Aug; 152(2 Pt 2):114s-126s. PubMed ID: 6447741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The glycosphingolipid globoside as a serological marker on cytolytic T lymphocyte precursors and alloantigen-responsive proliferating T lymphocytes in murine spleen.
    Mühlradt PF; Bethke U; Monner DA; Petzoldt K
    Eur J Immunol; 1984 Sep; 14(9):852-8. PubMed ID: 6236992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant DNA-derived interferons-alpha and -beta modulate the alloactivated proliferative response of bulk and cloned human lymphocytes.
    Chen BP; Sondel PM
    J Biol Response Mod; 1985 Jun; 4(3):287-97. PubMed ID: 3160832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
    Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
    Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody analysis of responder and stimulator cells in the human autologous mixed lymphocyte reaction.
    Nikaein A; Stelzer G; Duquesnoy RJ; Wallace JH
    Immunobiology; 1984 Mar; 166(2):190-202. PubMed ID: 6233217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of cytotoxic T lymphocytes in vitro. VI. Effect of cell density on response in mixed leukocyte cultures.
    Fitch FW; Engers HD; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1975 Dec; 115(6):1688-94. PubMed ID: 127012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor.
    Tan P; Anasetti C; Martin PJ; Hansen JA
    J Immunol; 1990 Jul; 145(2):485-8. PubMed ID: 1973183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allospecific suppression without requirement for participation of Ly 2+ cells.
    Holán V; Mitchison NA
    Immunology; 1984 Mar; 51(3):469-75. PubMed ID: 6199292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking of T cell activation at the G1A/G1B interface of the cell cycle and prevention of expression of interleukin 2 receptors by alloactivated suppressor T lymphocytes.
    Loertscher R; Leichtman AB; Williams JM; Strom TB
    Transplantation; 1988 Jan; 45(1):194-201. PubMed ID: 2962349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of in vitro cytotoxic T lymphocyte generation. II. Demonstration of noncytotoxic alloantigen-specific suppressor T lymphocytes.
    Schwartz A; Sutton SL; Gershon RK
    Eur J Immunol; 1982 May; 12(5):380-6. PubMed ID: 6212258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural regulatory cells in murine bone marrow: inhibition of in vitro proliferative and cytotoxic responses to alloantigens.
    Dorshkind K; Klimpel GR; Rosse C
    J Immunol; 1980 Jun; 124(6):2584-8. PubMed ID: 6445382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency in human peripheral blood of T cells which respond to self, modified self and alloantigens.
    Smith JB
    Immunology; 1983 Oct; 50(2):181-7. PubMed ID: 6225725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
    Klyushnenkova E; Mosca JD; Zernetkina V; Majumdar MK; Beggs KJ; Simonetti DW; Deans RJ; McIntosh KR
    J Biomed Sci; 2005; 12(1):47-57. PubMed ID: 15864738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures.
    Hall BM; Robinson CM; Plain KM; Verma ND; Carter N; Boyd RA; Tran GT; Hodgkinson SJ
    Transpl Immunol; 2008 Feb; 18(4):291-301. PubMed ID: 18158114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.